These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 31670914)
1. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia. Xu P; Zhou D; Yan G; Ouyang J; Chen B Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Li Z; Huang H; Li Y; Jiang X; Chen P; Arnovitz S; Radmacher MD; Maharry K; Elkahloun A; Yang X; He C; He M; Zhang Z; Dohner K; Neilly MB; Price C; Lussier YA; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Bullinger L; Valk PJ; Delwel R; Lowenberg B; Liu PP; Marcucci G; Bloomfield CD; Rowley JD; Chen J Blood; 2012 Mar; 119(10):2314-24. PubMed ID: 22251480 [TBL] [Abstract][Full Text] [Related]
3. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia. Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365 [TBL] [Abstract][Full Text] [Related]
4. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia. Fang Z; Wang X; Wu J; Xiao R; Liu J Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia. Guo Y Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110 [TBL] [Abstract][Full Text] [Related]
6. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137 [TBL] [Abstract][Full Text] [Related]
8. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia. Huang Y; Zou Y; Lin L; Ma X; Chen H Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis. Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095 [TBL] [Abstract][Full Text] [Related]
10. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression. Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297 [TBL] [Abstract][Full Text] [Related]
12. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. Lin X; Wang Z; Wang Y; Feng W Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789 [TBL] [Abstract][Full Text] [Related]
13. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705 [TBL] [Abstract][Full Text] [Related]
14. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia. Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964 [TBL] [Abstract][Full Text] [Related]
15. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia. Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096 [TBL] [Abstract][Full Text] [Related]
16. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. Zhi F; Cao X; Xie X; Wang B; Dong W; Gu W; Ling Y; Wang R; Yang Y; Liu Y PLoS One; 2013; 8(2):e56718. PubMed ID: 23437222 [TBL] [Abstract][Full Text] [Related]
17. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia. Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia. Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia. Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia. Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]